Affordable Access

deepdyve-link
Publisher Website

Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency.

Authors
  • Pasrija, Chetan1
  • Tran, Douglas2
  • George, Praveen2
  • Sorensen, Erik3
  • Kaczorowski, David J4
  • Ton, Van-Khue2
  • Kon, Zachary N5
  • 1 Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Md. Electronic address: [email protected]
  • 2 Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Md.
  • 3 Division of Clinical Engineering, University of Maryland Medical Center, Baltimore, Md.
  • 4 Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Md.
  • 5 Department of Cardiothoracic Surgery, New York University Langone Health, New York, NY.
Type
Published Article
Journal
The Journal of thoracic and cardiovascular surgery
Publication Date
Apr 01, 2020
Volume
159
Issue
4
Identifiers
DOI: 10.1016/j.jtcvs.2019.03.098
PMID: 31128896
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Severe renal insufficiency is considered a relative contraindication to left ventricular assist device (LVAD) implantation. After establishing an algorithmic approach to these patients, we hypothesized that LVAD implantation with severe renal insufficiency could be performed without increasing morbidity or mortality. All consecutive patients (July 2015-December 2017) who underwent LVAD implantation were retrospectively reviewed. Patients were stratified by preoperative glomerular filtration rate (GFR): ≤30 mL/min/1.73 m2 (low-GFR) and >30 mL/min/1.73 m2 (high-GFR). Preoperative optimization included aggressive inotropic support and temporary mechanical circulatory support before LVAD implantation in any patient with an acute component of renal insufficiency. All patients with a preoperative GFR ≤15 mL/min/1.73 m2 were prophylactically initiated on temporary renal replacement therapy postoperatively. The primary outcome was Kaplan-Meier 1-year survival. Fifty-eight patients (21 with low-GFR and 37 with high-GFR) were identified. Patients in the low-GFR cohort had a significantly higher median Interagency Registry for Mechanically Assisted Circulatory Support score and worse preoperative end-organ function. Preoperative optimization resulted in an increase in GFR to >30 mL/min/1.73 m2 in 11 out of 21 patients from the low-GFR cohort. Inotrope days, ventilator time, intensive care unit length of stay, and hospital length of stay were not significantly different between the groups. Kaplan-Meier 1-year survival was 81% in the low-GFR cohort and 86% in the high-GFR cohort (P = .98). Subset analysis of GFR ≤15 mL/min/1.73 m2 (n = 11) and ≥60 mL/min/1.73 m2 (n = 19) demonstrated identical 1-year survival (89% vs 89%; P = .91). LVAD implantation in carefully selected patients with severe renal insufficiency can be performed without increasing midterm morbidity or mortality. This strategy may serve as a successful option to bridge patients to transplantation or destination therapy. Copyright © 2019. Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times